1403362-16-2

Basic information

• Product Name: methyl (N-benzyl-benzyloxycarbonyl-5-aminopentyl 4-O-benzyl-7,8-O-isopropylidene-3-deoxy-α-D-manno-oct-2-ulopyranosid)onate
• Synonyms: methyl (N-benzyl-benzyloxycarbonyl-5-aminopentyl 4-O-benzyl-7,8-O-isopropylidene-3-deoxy-α-D-manno-oct-2-ulopyranosid)onate
• CAS NO: 1403362-16-2
• Molecular Weight: 691.819
• Mol File: 1403362-16-2.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: methyl (N-benzyl-benzyloxycarbonyl-5-aminopentyl 4-O-benzyl-7,8-O-isopropylidene-3-deoxy-α-D-manno-oct-2-ulopyranosid)onate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl (N-benzyl-benzyloxycarbonyl-5-aminopentyl 4-O-benzyl-7,8-O-isopropylidene-3-deoxy-α-D-manno-oct-2-ulopyranosid)onate(1403362-16-2)
• EPA Substance Registry System: methyl (N-benzyl-benzyloxycarbonyl-5-aminopentyl 4-O-benzyl-7,8-O-isopropylidene-3-deoxy-α-D-manno-oct-2-ulopyranosid)onate(1403362-16-2)

Safety Data

• Hazardous Substances Data: 1403362-16-2(Hazardous Substances Data)

Upstream product

• 1403362-15-1 C₃₂H₄₃NO₁₀ 
• 100-39-0 benzyl bromide 
• 1403362-14-0 C₂₉H₃₉NO₁₀ 
• 1403362-13-9 methyl (N-benzylbenzyloxycarbonyl-5-aminopentyl 4,5,7,8-tetra-O-acetyl-3-deoxy-α-D-manno-oct-2-ulopyranosid)onate 
• 1448614-11-6 C₄₃H₅₁NO₁₄Se 
• 85382-90-7 methyl-4,5,7,8-tetra-O-acetyl-2,6-anhydro-2,3-dideoxy-D-manno-oct-2-enosonat 
• 920958-49-2 benzyl-(5-hydroxy-pentyl)-carbamic acid benzyl ester 

Downstream Products

• 1403362-17-3 methyl [N-benzyl-benzyloxycarbonyl-5-aminopentyl (2,7-di-O-acetyl-3-O-levulinoyl-4-O-para-bromobenzyl-6-O-benzyl-L-glycero-α-D-manno-heptopyranosyl)-(1→5)-4-O-benzyl-7,8-O-isopropylidene-3-deoxy-α-D-manno-oct-2-ulopyranosid]onate 

Relevant articles and documents

TOTAL SYNTHESIS AND IMMUNOLOGICAL EVALUATION OF SACCHARIDE MOIETIES OF THE LIPOPOLYSACCHARIDE FROM NEISSERIA MENINGITIDIS

The present invention relates to the total chemical synthesis of the monosaccharide 35# (R' = H), the disaccharide 36# (R' ≠ H; R'' = H), the trisaccharide 37# (R' ≠ H; R'' ≠ H; R''' = H) and the tetrasaccharide 1#(R' ≠ H; R'' ≠ H; R''' ≠ H) of the following general formula wherein R represents –Y–NH2 Y represents a linker R' is H or R'' is H or R''' is H or of the lipopolysaccharide from Neisseria meningitidis, as well as to the trisaccharide 37# and the tetrasaccharide 1#, to vaccines containing at least one of the saccharides 1#, 35#, 36#, and 37# and to the use of such vaccine for immunization against diseases caused by infection with bacteria containing the tetrasaccharide α-GlcNAc-(1→2)-α- Hep-(1→3)-α-Hep-(1→5)-α-Kdo or the trisaccharide α-Hep-(1→3)-α-Hep-(1→5)-α- Kdo or α-GlcNAc-(1→2)-α-Hep-(1→3)-α-Hep, especially for immunization against meningitis, septicaemia, pneumonia and nasopharyngitis caused by Neisseria meningitidis.